Rodolfo Galindo, MD
Enriched profileAssociate Professor of Medicine, Division of Endocrinology, Diabetes and Metabolism · Leonard M. Miller School of Medicine
Rodolfo Galindo is Associate Professor of Medicine, Division of Endocrinology, Diabetes and Metabolism at Leonard M. Miller School of Medicine. OpenAlex indexes 214 publications with 6,829 citations (h-index 38); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Rodolfo Galindo, MD, is Associate Professor of Medicine, Division of Endocrinology, Diabetes and Metabolism at Leonard M. Miller School of Medicine, University of Miami. The public record shows 214 publications with 6,829 citations (h-index 38), centered on Endocrinology/Metabolic. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 16 companies, 2 NIH-funded awards (2023–2025).
- Most recent indexed publication: 2026 · Diabetes care
- Top research focus: Endocrinology/Metabolic
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 16 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Research focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 64 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
Industry payments
Updated 27 Aug 2026
16 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202514 payments$15,475openpaymentsdata.cms.gov ↗
- Novo Nordisk IncProgram year20256 payments$13,099openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
63.8%GLP-1 receptor agonist63.8%Mounjaro75%Ozempic25%Part D<11 patientsHormonal (systemic)
18.8%l-Thyroxine18.8%Levothyroxine Sodium100%Part D<11 patientsGenitourinary & hormones
17.4%Androgen17.4%Xyosted100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
2 NIH research awards on record, funded 2023–2025 per NIH RePORTER. The latest:
- Pharmaco-epidemiology of diabetes in patients with end-stage kidney disease
University of Miami School of Medicine
FY2025$115,125R03DK138255 - Use of Continuous Glucose Monitoring (CGM) in End-Stage Renal Disease(ESRD) Patients with Type 2 Diabetes
University of Miami School of Medicine
FY2024$180,005K23DK123384 - Pharmaco-epidemiology of diabetes in patients with end-stage kidney disease
University of Miami School of Medicine
FY2024$115,125R03DK138255
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Automated Insulin Delivery Systems in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis.
Diabetes care
Meta-analysis2026 - Comparative Effectiveness of Individual Sodium Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: Emulation of a Target Trial.
Journal of the American Heart Association
Article2026 - Weight stigma among diverse ethnic groups with obesity in the U.S.: the USA-OBESTIGMA study.
International journal of obesity (2005)
Article2026 - Expert Clinical Interpretation of Continuous Glucose Monitor Reports From Individuals Without Diabetes.
Journal of diabetes science and technology
Article2026
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/rodolfo-galindo-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- LinkedIn
LinkedIn: "Rodolfo Galindo - University of Miami" (auth-walled, corroborated by SERP snippet)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - ResearchGate
ResearchGate: "Rodolfo GALINDO | Professor (Associate) | University of Miami, Coral Gables | Endocrinology, Diabetes and Metabolism Division"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗ - Doximity
Doximity: "Dr. Rodolfo Galindo, MD – Miami, FL | Endocrinology"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Universidad de Ciencias Médicas de La Habana (University of Havana Institute of Medical Sciences)
2005verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pub.orcid.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →deceraclinical.com ↗
- Board certified
Internal Medicine (ABMS)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗ - Board certified
Diabetes, Metabolism & Endocrinology (ABMS)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗ - Internal Medicine residency
Albert Einstein College of Medicine / North Shore University Hospital, New York
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →practicingclinicians.com ↗ - Endocrinology fellowship
Albert Einstein College of Medicine / North Shore University Hospital, New York
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →practicingclinicians.com ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →practicingclinicians.com ↗
- Author/member
AACE Diabetes Mellitus Comprehensive Care Plan (2022) and AACE Type 2 Diabetes Management Algorithm
2023provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →practicingclinicians.com ↗ - Director
Comprehensive Diabetes Center, UHealth (University of Miami Health System)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →diabetesresearch.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrinenews.endocrine.org ↗
Secondary affiliations
appointments beyond the home institution- Diabetes Research Institute (DRI)
University of Miami
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →diabetesresearch.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →jacksonhealth.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →join.hcplive.com ↗
- Podcast guest
episode "Diabesidad", Conversaciones en Diabetes (Spotify)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →creators.spotify.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council